Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-18

FDA Approved: ALOSETRON HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for alosetron hydrochloride from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alosetron hydrochloride (Alosetron hydrochloride)

Snippet

SUPPL AP for ALOSETRON HYDROCHLORIDE (ALOSETRON HYDROCHLORIDE)